| 产品详情 |
| Edit |   |
|---|
| Product Name | Ponatinib |
|---|
| Description | MW: 532.56. Purity ≥98% by HPLC. Background: Ponatinib is a multi-targeted tyrosine kinase inhibitor that is active against T315I and other BCR-Abl mutants. It inhibits all tested BCR-Abl mutants in cellular and biochemical assays, suppresses BCR-Abl(T315I)-driven tumor growth in mice, and completely abrogates resistance in cell-based mutagenesis screens. |
|---|
| Size | 10 mg, 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-benzamide; AP24534] |
|---|
| Gene, Accession, CAS # | CAS: 943319-70-8 |
|---|
| Catalog # | MBS841931 |
|---|
| Price | |
|---|
| Order / More Info | Ponatinib from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|